TrialThe Lancet. Infectious diseases2021

Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.

Alistair R D McLean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.